+Search query
-Structure paper
Title | A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope. |
---|---|
Journal, issue, pages | Cell Rep Med, Vol. 2, Page 100344-100344, Year 2021 |
Publish date | Apr 14, 2020 (structure data deposition date) |
Authors | Raman, S. / Buongervino, S.N. / Lane, M.V. / Zhelev, D.V. / Zhu, Z. / Cui, H. / Martinez, B. / Martinez, D. / Wang, Y. / Upton, K. ...Raman, S. / Buongervino, S.N. / Lane, M.V. / Zhelev, D.V. / Zhu, Z. / Cui, H. / Martinez, B. / Martinez, D. / Wang, Y. / Upton, K. / Patel, K. / Rathi, K.S. / Navia, C.T. / Harmon, D.B. / Li, Y. / Pawel, B. / Dimitrov, D.S. / Maris, J.M. / Julien, J.P. / Bosse, K.R. |
External links | Cell Rep Med / PubMed:34337560 |
Methods | X-ray diffraction |
Resolution | 3.3 Å |
Structure data | PDB-6wjl: |
Source |
|
Keywords | Oncoprotein/Immune System / Neuroblastoma / Oncoprotein / Proteoglycan / Therapeutic antibody / Oncoprotein-Immune System complex |